Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced by Toll-like Receptor CD180 Ligation in Diffuse Cutaneous Systemic Sclerosis

被引:0
|
作者
Erdo-Bonyar, Szabina [1 ]
Rapp, Judit [1 ]
Subicz, Rovena [1 ]
Borocz, Katalin [1 ]
Szinger, David [1 ]
Filipanits, Kristof [2 ]
Minier, Tuende [2 ]
Kumanovics, Gabor [2 ]
Czirjak, Laszlo [2 ]
Berki, Timea [1 ]
Simon, Diana [1 ]
机构
[1] Univ Pecs, Clin Ctr, Dept Immunol & Biotechnol, Med Sch, H-7624 Pecs, Hungary
[2] Univ Pecs, Clin Ctr, Med Sch, Dept Rheumatol & Immunol, H-7632 Pecs, Hungary
关键词
CD180; systemic sclerosis; complement receptors; Toll-like receptors; natural autoantibodies; B cells; C3; anti-Scl-70; autoantibodies; NATURAL ANTIBODY; ACTIVATION; CLASSIFICATION; AUTOANTIBODIES; CYTOTOXICITY; PATHOGENESIS; ENDOTHELIUM; MECHANISMS; CR-2;
D O I
10.3390/ijms25179230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoantibody production is a hallmark of systemic sclerosis (SSc) and the most extensively studied role of B cells in the pathogenesis of the disease. However, the potential involvement of innate immune molecules in B-cell dysfunction in SSc is less understood. B-cell activation is an early event in the pathogenesis of SSc and is influenced by complement receptors (CRs) and Toll-like receptors (TLRs), shaping antibody responses. CR2 and CR1 modulate B-cell activation, and the roles of CR3 and CR4 are associated with autoimmune conditions. We investigated the expression of CRs in B cells from patients with the more severe form of the disease, diffuse cutaneous SSc (dcSSc), and the effect of TLR CD180 ligation on their expression. We found no significant difference in the basal expression of CD21 and CD11c in B cells between dcSSc and healthy controls (HCs). However, reduced basal CD11b expression in B cells in dcSSc compared to HCs, accompanied by a decrease in CD35 and an increase in CD11c expression following CD180 ligation may promote plasma cell formation and autoantibody production. Additionally, we searched for correlations between dcSSc-associated anti-DNA topoisomerase I (Scl-70) autoantibody, anti-citrate synthase (CS) natural autoantibody and complement component 3 (C3) levels and found a negative correlation between C3 and anti-CS autoantibody in dcSSc but not in HCs, supporting the hypothesis that natural autoantibodies could activate the complement system contributing to tissue injury in SSc.
引用
收藏
页数:9
相关论文
共 47 条
  • [41] Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)
    Tao, Yazhong
    Zhang, Xin
    Markovic-Plese, Silva
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 298 : 181 - 188
  • [42] Increased expression of CD25, CD83, and CD86, and secretion of IL-12, IL-23, and IL-10 by human dendritic cells incubated in the presence of Toll-like receptor 2 ligands and Giardia duodenalis
    Janine Obendorf
    Pablo Renner Viveros
    Michael Fehlings
    Christian Klotz
    Toni Aebischer
    Ralf Ignatius
    Parasites & Vectors, 6
  • [43] Increased expression of CD25, CD83, and CD86, and secretion of IL-12, IL-23, and IL-10 by human dendritic cells incubated in the presence of Toll-like receptor 2 ligands and Giardia duodenalis
    Obendorf, Janine
    Viveros, Pablo Renner
    Fehlings, Michael
    Klotz, Christian
    Aebischer, Toni
    Ignatius, Ralf
    PARASITES & VECTORS, 2013, 6
  • [44] Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH1 T-cells
    Marques-Piubelli, Mario L. L.
    Seervai, Riyad N. H.
    Mudaliar, Kumaran M. M.
    Ma, Wencai
    Milton, Denai R.
    Wang, Jing
    Muhlbauer, Aaron
    Parra, Edwin R. R.
    Solis, Luisa M. M.
    Nagarajan, Priyadharsini
    Speiser, Jodi
    Hudgens, Courtney
    Cho, Woo Cheal
    Aung, Phyu P. P.
    Patel, Anisha
    Pacha, Omar
    Nelson, Kelly C. C.
    Tetzlaff, Michael T. T.
    Amaria, Rodabe N. N.
    Torres-Cabala, Carlos A. A.
    Prieto, Victor G. G.
    Wistuba, Ignacio I. I.
    Curry, Jonathan L. L.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2023, 50 (07) : 661 - 673
  • [45] Lipopolysaccharide Enhances Wnt5a Expression through Toll-like Receptor 4, Myeloid Differentiating Factor 88, Phosphatidylinositol 3-OH Kinase/AKT and Nuclear Factor Kappa B Pathways in Human Dental Pulp Stem Cells
    He, Wenxi
    Wang, Zhihua
    Zhou, Zeyuan
    Zhang, Yaqing
    Zhu, Qinglin
    Wei, Kewen
    Lin, Yuan
    Cooper, Paul R.
    Smith, Anthony J.
    Yu, Qing
    JOURNAL OF ENDODONTICS, 2014, 40 (01) : 69 - 75
  • [46] High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
    Chen, Xue
    Zhang, Qi
    Luo, Youjun
    Gao, Caixia
    Zhuang, Xibing
    Xu, Guoxiong
    Qiao, Tiankui
    ONCOTARGETS AND THERAPY, 2016, 9 : 6511 - 6518
  • [47] Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B
    Li, J.
    Wang, F. -P.
    She, W. -M.
    Yang, C. -Q.
    Li, L.
    Tu, C. -T.
    Wang, J. -Y.
    Jiang, W.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (02) : 129 - 140